Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	1-Lucentis Monthly	301
Overall Study	STARTED	2-Avastin Monthly	286
Overall Study	STARTED	3-Lucentis as Needed	298
Overall Study	STARTED	4-Avastin as Needed	300
Overall Study	COMPLETED	1-Lucentis Monthly	284
Overall Study	COMPLETED	2-Avastin Monthly	265
Overall Study	COMPLETED	3-Lucentis as Needed	285
Overall Study	COMPLETED	4-Avastin as Needed	271
Overall Study	NOT COMPLETED	1-Lucentis Monthly	17
Overall Study	NOT COMPLETED	2-Avastin Monthly	21
Overall Study	NOT COMPLETED	3-Lucentis as Needed	13
Overall Study	NOT COMPLETED	4-Avastin as Needed	29

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00593450/flow